|
| |
NEWS
|
Geneva
25.09.2008
HHC is
pleased to announce that a specific youtube page is now available. This
page will be implemented in the next months and furnished with short
movies presenting our products and relevant scientific news.
With
best regards,
Helvetica Health Care Sàrl
|
|
Geneva
27.08.2008
HHC in
association with Nucleon Ltd is taking part to the 20th UICC World
Cancer Congress from 27 to 31 Auust 2008 in Geneva. Through our presence
(stand n°1116) we will promote the advantages and benefits of using
Cytoactiv the first prognostic marker for cervical dysplasia.
With
best regards,
Helvetica Health Care Sàrl
|
|
Geneva
28.01.2008
Cytoimmun
diagnostics was presented
with the
2007 Medical Innovation of
the year award by the
Rhineland-Palatinate Ministry of Labor, Social Services, Health, Family
and Women for the developpment of cytoactiv.
Cytoactiv is distributed by HHC.
For further details please visit this page
here
With
best regards,
Helvetica Health Care Sàrl
|
|
Geneva
29.11.2007
Helvetica
Health Care is pleased to announce the signing of an agreement with Nucleon
Ltd and Cytoimmun GmbH
for the exclusive distribution of Cytoactiv in UK, France, Spain,
Portugal, Latin America, South East Asia and the Middle East.
The
new agreement enables Cytoimmun to offer the global market the first
prognostic marker that gives reliable information for cancer prevention.
For
furher information for your territory, please visit
http://www.helveticahealthcare.com/Cytoactiv.
For
Eastern Europe, Africa and the Indian subcontinent, please visit
www.nucleon.biz
For
other countries, please visit
www.cytoimmun.com
With
best regards,
Helvetica Health Care Sàrl
|
|
|
|
|
|
2007 END OF YEAR
PROMOTION
20% DISCOUNT on all NATtrol ORDERS
placed before 31st DECEMBER
2007* !
NATtrolTM
Nucleic Acid Test Standards (link to our website on each type of products)
|
Volume
|
Target
|
List
price
CHF
|
Promotional
price CHF
|
List
price
EUR
|
Promotional
price EUR
|
|
1
mL
|
400
cp/mL
|
108.00
|
86.40
|
70.00
|
56.00
|
|
1
mL
|
5,000
cp/mL
|
198.00
|
158.40
|
129.00
|
103.20
|
|
1
mL
|
10,000
cp/mL
|
294.00
|
235.20
|
191.00
|
152.80
|
|
1
mL
|
50,000
cp/mL
|
796.00
|
636.80
|
516.00
|
412.80
|
15% DISCOUNT on other
RESEARCH PRODUCTS from Zeptometrix and EY Labs* !
For any question, comment or request of quotation, do not
hesitate to contact us.
TEL +41 22 788 88 12 or +41 22 534 94 54 -
Fax +41 22 594 85 07
We look forward to hearing from you.
BEST REGARDS,
Customer Service
HELVETICA HEALTH CARE sàrl
PO Box 1158
CH - 1211 Geneva 5 AP
Switzerland
*Terms and conditions: orders placed on or before 31.12.07 and
delivered not later than 31.01.07 - this offer is not applicable on current
open contracts.
|
|
Geneva
8 August 2007
TO
WHOM IT MAY CONCERN
Dear
Madam or Sir,
We
would like to inform you that our mailing address has recently been changed. We
therefore kindly ask you to update your database accordingly.
This
is our new mailing address :
Helvetica
Health Care Sàrl
PO
Box 1158
1211
Geneva 5 AP
Switzerland
For
any question or comment you might have, we remain at your disposal.
Best
regards,
Helvetica Health Care Sàrl
|
|
Geneva,
29 June 2007
Company Announcement
Dear Customers,
Helvetica Health Care is pleased to announce that as part of our expansion
program, we have appointed a new Marketing and Sales Director.
Mr.
Michael Moore joins HHC with 25 years experience in the health care industry,
having held senior management positions with global leaders and blue chip
companies such as Wellcome Diagnostics, Murex Biotech, Abbott Laboratories and Genelabs
Diagnostics.
Prior
to joining HHC, Michael was Director of MP Biomedicals Suisse SA.
Michael's
knowledge of the industry, experience and network of contacts will be a
real asset to HHC and the strengthening our management team outlines HHC's
committment to providing our customers with products and service of the
highest quality.
HHC
can also confirm the recent agreement signed with Alliance Bio to
distribute their range of Molecular Biology products.
Further
details on these products are available on the HHC web site and our sales
& marketing team can provide more information on this exciting
opportunity.
We
hope to be able to provide more good news regarding further additions to
our product range in the near future.
Helvetica
Health Care Sàrl
|
| |
|
NEWS
|
HHC is pleased to announce that a specific youtube page is now
available. This page will be implemented in the next months and
furnished with short movies presenting our products and relevant
scientific news.
|
HHC in association with Nucleon Ltd is taking part to the 20th UICC
World Cancer Congress from 27 to 31 Auust 2008 in Geneva. Through our
presence (stand n°1116) we will promote the advantages and benefits of
using
Cytoactiv the first prognostic marker for cervical dysplasia.
|
|
